• Company
• Livtencity aims to enter the reimbursement market
• by Eo, Yun-Ho Oct 27, 2023 05:33am

• Policy
• Final PVA improvement plan to be prepared soon
• by Lee, Tak-Sun Oct 27, 2023 05:33am

• Company
• The Key to Competitiveness is 'OS·Brain metastasis'
• by Oct 26, 2023 06:07am

• Company
• Seo Jeong-jin, targets sales of 5 trillion won for new drugs
• by Kim, Jin-Gu Oct 26, 2023 06:06am

• Policy
• Minister Cho will work to address shingles vaccine issue
• by Lee, Hye-Kyung Oct 26, 2023 06:06am

• Policy
• Prostate cancer tx Xtandi·Zytiga, 5% pt copayment applied
• by Lee, Tak-Sun Oct 26, 2023 06:06am

• Policy
• Will restrictions be eased for vaccine clinical trials?
• by Lee, Jeong-Hwan Oct 26, 2023 06:06am

• Company
• Verzenio reattempts reimb for early breast cancer in KOR
• by Eo, Yun-Ho Oct 26, 2023 06:06am

• Company
• Janssen ‘will continue endeavors to the Korean society’
• by Son, Hyung-Min Oct 25, 2023 11:08am

• Company
• JW Pharma terminates contract after 5 yrs of atopy new drug
• by Chon, Seung-Hyun Oct 25, 2023 05:25am